Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)

NCT04140110 is registered in ClinicalTrials.gov with The George Institute for Global Health, China as lead sponsor.

NCT NCT04140110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04140110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)
Lead sponsor
The George Institute for Global Health, China
Phase
Not applicable
Overall status
Terminated
Start date
July 20, 2020
Completion date
October 31, 2022
Enrollment
816 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke